Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
broader decrease » greater decrease (Expand Search), broader debate (Expand Search), road decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
broader decrease » greater decrease (Expand Search), broader debate (Expand Search), road decreased (Expand Search)
-
2061
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2062
-
2063
-
2064
-
2065
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2066
-
2067
-
2068
-
2069
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2070
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2071
-
2072
-
2073
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2074
-
2075
-
2076
-
2077
-
2078
-
2079
-
2080